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Abstract
Methylmalonic acidurias (MMAurias) are a group of inherited disorders in the catabolism of branched-chain amino acids, odd-
chain fatty acids and cholesterol caused by complete or partial deﬁciencyofmethylmalonyl-CoAmutase (mut0 andmut- subtype
respectively) and by defects in the metabolism of its cofactor 5′-deoxyadenosylcobalamin (cblA, cblB or cblD variant 2 type).
A long-term complication found in patients with mut0 and cblB variant is chronic tubulointerstitial nephritis. The underlying
pathomechanism has remained unknown.We established an in vitromodel of tubular epithelial cells from patient urine (hTEC;
9 controls, 5 mut0, 1 cblB). In all human tubular epithelial cell (hTEC) lines we found speciﬁc tubular markers (AQP1, UMOD,
AQP2). Patient cells showed disturbance of energymetabolism in glycolysis, mitochondrial respiratory chain and Krebs cycle in
concert with increased reactive oxygen species (ROS) formation. Electron micrographs indicated increased autophagosome
production and endoplasmic reticulum stress, which was supported by positive acridine orange staining and elevated levels of
LC3 II, P62 and pIRE1. Screening mTOR signaling revealed a release of inhibition of autophagy. Patient hTEC produced and
secreted elevated amounts of the pro-inﬂammatory cytokine IL8,whichwashighly correlatedwith the acridine orange staining.
Summarizing, hTEC of MMAuria patients are characterized by disturbed energy metabolism and ROS production that lead to
increased autophagy and IL8 secretion.
Introduction
Methylmalonic acidurias (MMAurias) are an etiologically
heterogeneous group of inherited disorders in the catabolism of
L-isoleucine, L-valine, L-methionine and L-threonine as well as
odd-chain fatty acids and cholesterol with an cumulative preva-
lence of 1:50 000–1: 100 000 newborns (1). Isolated MMAurias are
caused by complete or partial deﬁciency of the mitochondrial
enzyme methylmalonyl-CoA mutase catalyzing the conversion
of methylmalonyl-CoA to succinyl-CoA (MCM; EC 5.4.99.2; mut0
enzymatic subtype or mut- subtype, respectively), or by defects
in the uptake, transport or synthesis of its cofactor 5′-deoxyade-
nosylcobalamin (cblA, cblB or cblD variant 2 type). Affected indivi-
duals display elevated levels of methylmalonic acid (MMA),
propionate, 3-hydroxypropionate and 2-methylcitrate in tissues
and body ﬂuids (2). Neonatal sepsis-like metabolic crisis after a
short symptom-free period may be the ﬁrst and life-threatening
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manifestation of MMAurias (2). Recurrent acute metabolic crises
are often triggered by catabolic state, e.g. due to febrile illness.
Major long-term complications are neurological impairment
(3,4) and chronic tubulointerstitial nephritis (cTIN) with progres-
sive impairment of renal function (5). Patientswithmut0 and cblB
defects bear the highest risk to develop cTIN (5). Severe disturb-
ance of mitochondrial energy metabolism due to synergistic
action of accumulating toxic metabolites, in particular propio-
nyl-CoA, has been suggested to underlie neurodegenerative
changes (6). Little is known about the pathomechanism of renal
disease.Mcm−/−mice only survive 48 h after birth limiting inves-
tigation of long-term complications (7). Stable expression ofMcm
in the liver of Mcm−/− mice has recently been shown to rescue
neonatal lethality but does not prevent renal dysfunction (8).
Proximal tubular cells of these mice displayed enlarged mito-
chondriawith disorganized cristae indicatingmitochondrial dys-
function, decreased glomerular ﬁltration rate, but no clear signs
of inﬂammation or cTIN were reported. Similar morphological
changes have been described in patients (9), however combined
with inﬁltration of immune cells. Therefore, the renal phenotype
of the existing mouse models rather resembles tubular atrophy.
Interestingly, it has been found that the pattern of excreted
cells in the urine correlates with the progression nephritis (10).
To gain further insight in the renal pathogenesis we therefore es-
tablished and characterized an in vitromodel of tubular epithelial
cells gained from urine of affected patients. As additional con-
trols we used tubular epithelial cells from propionic aciduria
(PAuria) patients. This disease is caused by deﬁciency of the en-
zyme propionyl-CoA carboxylase catalyzing the decarboxylation
of propionyl-CoA to methylmalonyl-CoA and, therefore, lying
one enzymatic step before MCM. Importantly, PAuria patients
display neurological disease andmyopathies but do not typically
develop cTIN.
Results
Characterization of human proximal tubule cells
We puriﬁed human tubular epithelial cells (hTEC) from 9 healthy
controls (Co_1–9), 3 PAuria patients (PA_1–3), 5 mut0 patients
(mut0_1–5) and one cblB patient (cblB_1). Since cblB patients
have the same risk to develop cTIN (5) and hTEC of the latter pa-
tient did not differ from hTEC ofmut0 in any of the performed ex-
periments, we combined both disease subtype under MMAuria
patients for data analysis in the text and refer to ‘mut’ in ﬁgures
due to space limitations. All included mut0 patients showed in-
creased creatinine clearance as well as elevated MMA concentra-
tions in urine and plasma (data not shown). Age range of controls
was between 3 and 37 years, mut0 patients ranged between 11–40
years and PA patients between 1 and 7 years (Table 1).
Next, hTEC were tested for expression of speciﬁc marker pro-
teins for different kidney segments. Supplementary Material,
Figure S1 shows representative immunoblots for these markers
(AQP1, UMOD, AQP2) and MCM. hTEC from control and patients
with MMAurias express markers of the proximal and distal
tubule as well as of the thick ascending limb. A high expression
of Mcm is observed in control cells. In mut0_1, 2 we could not
detect MCM, whereasmut0_3, 5 and cblB_1 show reduced expres-
sion. This is probably due to the fact that the anti-MCM antibody
recognizes the whole enzyme, thus may interact with parts of
non-functional enzyme present in these cells. The cells derived
from healthy controls and MMAuria patients were investigated
for MCM activity using 14C incorporation assay conﬁrming
the enzymatic defect (data not shown). Stimulation with
adenosylcobalamin showed that all mut0 cell lines are unrespon-
sive to cofactor stimulation (data not shown). Consistently,
MMAuria patient hTEC showed increased MMA secretion (Fig. 1).
Summarizing, hTEC lines gained from human urine express
characteristic markers of tubular epithelial cells. Further,
MMAuria patient cell lines display the corresponding enzymatic
and metabolic phenotype.
Proﬁling energy metabolism
As disturbance of energy metabolism is thought to play a major
role in the pathogenesis of MMAurias, we assessed cellular en-
ergy homeostasis in hTEC on various levels. First, we determined
mitochondrial respiration in DMEM+10% FCS and Krebs Ringer
buffer (KRB) pyruvate (5 m) to directly stimulate mitochondrial
respiration. hTEC of PA and MMAuria patients displayed de-
creasedmitochondrial respiration in standard medium, whereas
only cells of MMAuria patients revealed a diminished ability to
respire on pyruvate (Fig. 2A). It has been previously shown that
the metabolite propionyl-CoA accumulating in PA and MMAuria
inhibits pyruvate and 2-oxoglutarate dehydrogenase complex
(11). Therefore we measured the mitochondrial pyruvate and 2-
oxoglutarate catabolism by radiometric analysis. hTEC of PA pa-
tients showed a decreased 14C-CO2 production from pyruvate,
whereas 2-oxoglutarate catabolism was slowed in cells from
MMAuria patients (Fig. 2B). Next, we analyzed energy metabol-
ism on the level of single enzymes, i.e. respiratory chain and gly-
colysis. Of note, phosphofructokinase (PFK1) activity was
speciﬁcally reduced in hTEC of MMAuria patients (Fig. 2C). Lac-
tate dehydrogenase activity was increased in these cells. Next
we aimed to determine activity of respiratory chain complexes,
Table 1. Included MMAuria patients
hTEC Age Mutation MMA in plasma (μM)
mut0_1 22 T862C, T862C 4112 (±1430)
mut0_2 23 C982T, C982T 4239 (±2845)
mut0_3 18 G607A, G607A 1230 (±414)
mut0_4 11 G607A, C1105Ts 3278 (±1527)
mut0_5 16 T862C, A1157G 4579 (±1527)
cblB_1 40 C556T, Arg186W 3143 (±453)
Figure 1. Characterization of hTEC. In line with their genotype, hTEC of MMAuria
patients displayed elevated MMA production compared with control cells. Data
are presented as dot plots, ctrl n = 9, mut n = 6 *P < 0.05.
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but we failed to gain mitochondrial preparations from hTEC of
MMAuria patients.We tested different systems for cell homogen-
ization (disruption with needles of different gauges, various
Potter-Elvehjem homogenizers) and subcellular fractionation
techniques (differential centrifugation versus density gradient
centrifugation), but wewere not able to achieve a sufﬁcient qual-
ity and quantity ofmitochondrial enrichment. To circumvent the
need of mitochondrial fraction, we used digitonin permeabilized
cells to record respiratory chain complex activities (12). In line
with the notion of decreased mitochondrial respiration due to
Figure 2. Dysfunction of energy metabolism. To assess energy metabolism in hTEC we performed metabolic ﬂux experiments and recorded single enzyme activities of
major pathways in control cells as well as hTEC of MMAuria and PAuria patients. (A) First, we analyzed mitochondrial respiration standard DMEM and KRB+4 mM
pyruvate. hTEC of MMAuria and PAuria patients displayed reduced mitochondrial respiration in DMEM, whereas only MMAuria patient hTEC had a lower oxygen
consumption on the substrate pyruvate. In line with this ﬁnding, (B) both patient cell lines revealed a reduced 14CO production on the substrate 14C-2-oxoglutarate,
but break down of 14C-pyruvate was only altered in PAuria hTEC. (C) Analysis of single enzymes of glycolysis (HK: hexokinase; PFK: phosphofructokinase; TPI: triose
phosphate isomerase; GAPDH: glyceraldehydphosphat-dehydrogenase; PGM: phosphoglycerate mutase; E: enolase; PK HA: pyruvate kinase M2 tetramer; PK LA:
pyruvate kinase M2 dimer; LDH: lactate dehydrogenase) showed a strongly diminished PFK and an increase of LDH activity in hTEC of MMAuria patients. Adding to
the ﬁnding of disturbed mitochondrial energy metabolism in these cell lines, we found a reduction of cytochrome c oxidase (D) and aconitase (E; CS, citrate synthase;
MDH, malate dehydrogenase, FUM, fumarase; IDH, isocitrate dehydrogenase; ACO, aconitase). Data are presented as dot plots (A, B and D) or box plots (C and E), ctrl
n = 5, PA n = 3, mut n = 6 * P < 0.05.
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disturbed integrity of mitochondrial membranes, cytochrome c
oxidase activity was diminished in hTEC of MMAuria patients
(Fig. 2D).
Using this approach we also determined activity of citrate
cycle enzymes. In hTEC of MMAuria patients we found decreased
activity of aconitase (Fig. 2E). Other investigated proteins of
citrate cycle were unchanged in their activity.
Generation of reactive oxygen species
Oxidative stress is commonly found in conditions of disturbed
energy metabolism, particularly involving the respiratory
chain. First, we evaluated glutathione status as a general marker
of increased reactive oxygen species (ROS) generation. hTEC of
MMAuria patients indeed showed decreased levels of reduced
and increased levels of oxidized glutathione (Fig. 3A). Next, we
used H2DCFDA staining and FACS analysis to measure the actual
ROS generation (Fig. 3B). Cells were cultivated in KRB and energy
substrates (glucose, pyruvate or glutamine) in the presence or
absence of PA, MMA and isoleucine. Regardless of the supplied
substrate, hTEC of MMAuria patients generated more ROS than
control cells or PA patient cells. Incubation of MMAuria cells in
Williams′ medium E which is enriched with anti-oxidative
agents (i.e. glutathione, ascorbic acid) did reduce ROS production
compared with the condition KRB + pyruvate stimulating mito-
chondrial activity (P = 0.03).
Figure 3. Oxidative stress in hTEC of MMAuria patients. Oxidative stress and ROS production were investigated by analyzing glutathione status (A) as well as by the ROS
sensitive dye H2DCFDA (10 μM, (B). Total glutathione content was unchanged in hTEC of MMAuria patients, but the amount of oxidized glutathione (GSSG) was increased
and the level of reduced glutathione (GSH) diminished in these cells. FACS analyses with H2DCFDA stained cells showed increased formation of ROS in hTEC of MMAuria
patients in all tested conditions, i.e.Williams Emedium, KRB supplementedwith glucose (Glc), pyruvate (Pyr), glutamine (Gln), propionic acid (PA), MMA or isoleucine (Ile;
each 5 mM). Data are presented as dot plots (A) or box plots (B), ctrl n = 5, PA n = 3, mut n = 6 *P < 0.05*.
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Induction of autophagy
Electron micrographs of hTECs showed lamellar bodies and di-
lated endoplasmic reticulum (ER) indicative of autophagic
changes and ER stress respectively (Fig. 4). To this endwe stained
hTEC with acridine orange and analyzed the amount of green
ﬂuorescing cells (staining of autophagosomes) by FACS analysis.
MMAuria patient cells displayed elevated green staining indicat-
ing enhanced autophagic processes (Fig. 5A).Moreover, increased
levels of the autophagy marker proteins LC3 II and p62 in these
cells corroborate the rise in autophagosomes (Fig. 5B) which
was not found in hTEC of PA patients (Fig. 5C). Application of ra-
pamycin as control experiment led to strong induction of autop-
hagy and increased levels of LC3 II and p62.
mTOR complex is a master regulator of autophagy and itself
tightly regulated by the energetic state of the cell and nutrient
availability, most importantly branched-chain amino acids (13).
Of note, the ﬁnal degradation pathway of the latter is interrupted
in MMAuria due to the defect of MCM. To stimulate the mTOR
pathway and its response to nutritional signals we cultivated
hTEC under low protein conditions, i.e. 0.5 and 1% FCS, and
high protein conditions, i.e. 20% FCS. In MMAuria patients the
recommended therapeutic regiment aims to reduce the daily
protein intake which is a major risk factor for metabolic decom-
pensation. We studied the levels of mTOR, Phospho-mTOR
(Ser2448), Phospho-Raptor (Ser792) PRAS40, Phospho-PRAS40
(Thr246), RagC in hTEC of MMAuria as well as PA patients relative
to control cells used in the same experiments. Phospho-Raptor
and RagC levels remained unchanged in hTEC of MMAuria and
PAuria patients (data not shown), whereas MUT-deﬁcient cells
responded to an increasing protein load with decreasing ratios
of Phospho-mTOR to mTOR as well as of Phospho-PRAS40 to
PRAS40 (Fig. 5D). Decreasing phosphorylation level of these pro-
teins reverses the inhibition of autophagy by mTOR complex.
Neither hTEC of healthy donors nor of PAuria patients (Fig. 5E)
showed this pattern of mTOR regulation. Next, we examined
whether the pro-autophagic modulation of mTOR complex by
protein loading is associatedwith increased LC3 II und p62 levels.
hTEC of MMAuria patients were indeed characterized by elevated
levels of these proteins when media were supplemented with
20% FCS (Fig. 5B). Decreasing FCS concentrations to 1 and 0.5%
abolished this effect and MCM-deﬁcient cells were undistin-
guishable from control cells. Again, hTEC of PAuria patients
responded to this treatment like control cells conﬁrming the spe-
ciﬁcity of our results (Fig. 5C). AMPK is a key sensor for the cellular
energetic state and modulates mTOR activation. However, we
could not ﬁnd increased phosphorylation of AMPK in hTEC of
MMAuria or PAuria patients (data not shown).
As a sensor of ER stress we studied the ER transmembrane
protein phosphorylated inositol requiring enzyme 1α (pIRE1)
again under different FCS conditions (0.5, 1, 20%) revealing an in-
crease in pIRE1 (Fig. 5B) in MUT-deﬁcient cells but not in hTEC of
PAuria patients (Fig. 5E).
Inﬂammatory phenotype
Disturbance of renal tubular energymetabolism is commonly as-
sociated with Fanconi syndrome due to lack of energy for tubular
transporter. Interestingly, MMAuria patients directly develop
cTIN despite impaired energy homeostasis. To gain more insight
in the underlying mechanism, we aimed to describe inﬂamma-
tory molecules generated by patient hTEC. We used a Mix-
N-Match ELISArray Kits (SABiosciences) for major cytokines
released by the proximal tubule, i.e. IL8, MCP1, MIP-1a, MIP-1b,
RANTES, TGF-ß. In addition, we analyzed the expression of sev-
eral receptors of the complement systemCD55, CD46, CD59, CD88
by FACS. Whereas the latter receptors remained unchanged, the
Mix-N-Match ELISArray indicated elevated production and secre-
tion of IL8 in hTEC of MMAuria patients (data not shown). Using a
quantitative IL8 ELISA (Eli-pair Kit, abcam) we determined the
amount of this cytokine secreted to the apical and basolateral
site of 12-well Transwell plate as well as its intracellular concen-
tration. Our experiments conﬁrmed that MMAuria hTEC pro-
duced and secreted more IL8 than control or PAuria patient
hTECs (Fig. 6).
Discussion
To investigate the molecular mechanisms of cTIN in MMAurias,
we established tubular epithelial cell lines (hTEC) from affected
patients as well as control cell lines from healthy donors
and PAuria patients. Molecular characterization of these cells
Figure 4. Alterations in ultrastructure. Electron micrographs of all mut0 hTEC provided indication of increased autophagy and ER stress. Figure 4 shows representative
electron micrographs of mut0_1. Patient hTEC display an increased number of lamellar bodies (A) as well as bloated and disarranged ER structures (B) indicative of
autophagic processes and ER stress respectively.
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revealed expression of speciﬁc marker proteins of the proximal
and distal tubules as well as thick ascending limb to a similar
degree in all cell lines. It has previously been shown that the pat-
tern of excreted cells in the urine correlates with the progression
nephritis (10). Therefore, our hTEC model disease state and
damaged area of tubule of the corresponding patients.
Dysfunction of energy metabolism and ROS production
It has previously been shown that in MMAuria and PAuria accu-
mulating metabolites can directly inhibit energy metabolism
(11,14,15). To evaluate overall energy metabolism in hTEC, we
measured mitochondrial oxygen consumption in standard
Figure 5.Autophagyand regulation ofmTOR. Speciﬁcally hTECofMMAuria patients showed an increased stainingwith acridine orange indicating elevated autophagy (A).
Since autophagyandmTORare regulated by the energetic status of the cell, we cultured hPTEC inDMEMsupplementedwith 0.5, 1 or 20% to simulate lowandhigh protein/
nutritional energy levels. Elevation of FCS content in medium resulted in an up-regulation of LC3 II and p62 levels (B) as well as in a down-regulation of the ratios of
phosphorylated to unphosphorylated mTOR and phosphorylated to unphosphorylated PRAS40 (D) in hTEC of MMAuria patients. Moreover, increased pIRE1 levels
under high FCS conditions indicated ER stress (B). Similar patterns for alterations in autophagy and ER stress response (C) as well as mTOR signaling (D) were not
found in hTEC from PAuria patients. Data are presented as dot plots (A) or mean (B–E), ctrl n = 5, PA n = 3, mut n = 6 *P < 0.05.
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DMEM and KRB including pyruvate. hTEC of PAuria andMMAuria
patients showed a strong decrease of mitochondrial respiration
in DMEM, whereas this decrease was only found for hTEC of
MMAuria patients in KRB including pyruvate. Further enzymatic
analysis showed decreased activity of PFK1,mitochondrial aconi-
tase, OGDHc and cytochrome c-oxidase. PFK1 is a rate limiting
enzyme of glycolysis highly regulated by ATP, ADP, AMP, citrate
and fructose 2,6-bisphosphate. Of note, we found that 2-methyl-
citrate is a strong PFK inhibitor (1 mM ∼80% reduction of enzyme
activity). Since citrate allosterically inhibits PFK, the observed
decrease of PFK activity can be caused by accumulating 2-
methylcitrate in hTEC. Alternatively, Tp53-induced glycolysis
and apoptosis regulator (TIGAR) has been shown to block PFK ac-
tivity in ischemic proximal tubules to protect these from energy
depletion and apoptotic cell death (16).
The reduction of mitochondrial respiration as well as cyto-
chrome c-oxidase activity in concert with the observed fragility
of mitochondria strongly hints to a defect inmitochondrial mem-
brane composition. Of note, the same phenomenonwas observed
in the attempt to purify mitochondria from Mut-deﬁcient mice
(17). Reduced activity of cytochrome c-oxidase (18) or even of all re-
spiratory chain complexes (9) has been found in kidney biopsies
from MMAuria. Taken together these ﬁndings suggest that mito-
chondrial integrity is altered in MMAuria.
The mitochondrial enzymes aconitase bears metal ions in its
catalytic center making it highly sensitive to ROS (19) and, conse-
quently, its reduced activity in hTEC of MMAuria patients was in-
dicating increased ROS production. In line with this notion hTEC
of MMAuria patients showed increased levels of glutathione
disulﬁde and a diminished content of reduced glutathione. More-
over, using the ROS sensitive dye H2DCFDA (20) we could show
that hTEC generate indeed more free oxygen radicals.
Increased autophagy in hTEC of MMAuria patients
In electronmicrographs of mut-deﬁcient hTEC lamellar bodies indi-
cated increased production of autophagosomes and autolysosomes.
Induction of autophagy has been shown to be a cellular response
to chronic, metabolic mitochondrial stress in kidney cells (21). In-
deed, speciﬁcally hTEC of MMAuria patients displayed increased
levels of LC3 II and p62 under metabolic stress, i.e. high FCS con-
tent. Both proteins play a central role in the maturation of the au-
tophagosomes (22). Elevation of AO positive stained cells further
supports the notion of increased autophagy. mTORC1 is a master
regulator of macro-autophagy and a central energy sensor of the
cell. Moreover, maintenance and physiological functions of the
kidney are critically dependent on mTOR-modulated autophagy
(23). To investigate activation status and response of mTORC1 to
nutritional signals, we cultured hTEC in DMEM supplemented
with 0.5, 1 or 20% FCS. Elevation of FCS content in medium re-
sulted in a down-regulation of the ratios of phosphorylated to un-
phosphorylated mTOR and phosphorylated to unphosphorylated
PRAS40 in hTEC of MMAuria patients causing an inactivation of
mTORC1 and, thereby, of its inhibition of autophagy (24–27).
Interestingly, electron micrographs also displayed bloated ER
structures in hTEC of MMAuria patients indicating elevated ER
stress. There is growing evidence that mTORC1 and ER stress
are linked via the IRE1-JNK pathway (28) and that the crosstalk
of this two signaling axis may even orchestrate IL8 secretion
(29). Further, autophagy can be activated by IRE1 and eIF-2a
with PERK (30). In line with this notion, we found increased con-
tent of phosphorylated IRE1a hTEC of MMAuria patients.
Cytokine secretion
Recruitment of immune cells to inﬂamed tissue and communica-
tion at the site of inﬂammation occurs via cytokines and recep-
tors. Screening for the production and release of relevant
cytokines in our hTEC lines, we found elevated IL8 levels in and
secretion from cells of MMAuria patients. IL8 plays a central
role in chronic kidney disease including different forms of neph-
ritis and has been shown to be released by tubular epithelial cells
(31). Since cytokine secretion and, thereby, activation of immune
cells plays a pivotal role in the development of cTIN, we tested
whether mitochondrial dysfunction using cytochrome c oxidase
as indicator, ROS indicated by H2DCFDA staining, or autophagy
Figure 6. Production and secretion of IL-8. We detected intracellular content as well as secretion to the apical and basolateral compartment of IL8. Only hTEC of MMAuria
patients showed increased production and release of this cytokine. Data are presented as box plot, ctrl n = 5, PA n = 3, mut n = 6 *P < 0.05*.
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indicated by acridine orange staining would predict the extent of
IL8 production and secretion. Indeed, we found a high correlation
between acridine orange staining and the amount of IL8 pro-
duced and secreted by hTEC of MMAuria patients (Fig. 7; IL8 ver-
sus ROS production, R² = 0.47; IL8 versus cytochrome c oxidase,
R² = 0.55).
Figure 8 shows a synopsis of the postulated pathomechanism.
Deﬁciency of MCM leads through a yet unknown mechanism to
mitochondrial dysfunction characterized by impaired energy
production, ROS generation and loss of mitochondrial integrity.
These factors are sufﬁcient to trigger autophagy to clear defect
organelles and maintain cellular energy levels. A recent study
of Wrobel and colleagues has shown that decreased import of
mitochondrial proteins and their subsequent increased cytosolic
levels induce unfolded protein response (32). Disturbance of
mitochondrial integrity in hTEC of MMAuria patients will result
in impaired import of mitochondrial proteins which should ac-
cordingly lead via stimulation of unfolded protein response to
ER stress. In parallel, dysfunction of cellular energy production
releases mTOR-mediated inhibition of autophagy. The interplay
of autophagy and ER stress induce production and secretion
of IL8.
In summary, our study describes a new in vitromodel to study
the pathomechanism of cTIN inMMAuria consisting of immorta-
lized human, tubular epithelial cells. These cells express speciﬁc
markers of the proximal and distal tubules aswell as the thick as-
cending limb.We found in hTEC of MMAuria patients severe dys-
function of cellular energy metabolism as well as increased ROS
generation and autophagic processes that may lead to increased
cytokine (IL8) secretion and development of cTIN.
Materials and Methods
Patient material
The study was performed in accordance with the declaration of
Helsinki andwas approved by the Institutional Ethics Committee
Figure 7. Correlation of IL8 secretion and acridine orange staining. To link the
molecular and metabolic alteration, we tested whether there is a correlation
between the main ﬁndings of our study, i.e. mitochondrial dysfunction, ROS
production, autophagy and IL8 secretion. Indeed we found a very high
correlation between acridine orange positive stained cells and the extent of
secreted IL8.
Figure 8. Synopsis of postulated pathomechanism. hTEC of MMuria patients display reduced activities of cytochrome c oxidase (CIV) and aconitase (ACO) as well as
elevated ROS production. These alterations are most likely due to a loss of mitochondrial integrity. Cellular energy depletion and defect mitochondria elicit
autophagy. In parallel mitochondrial dysfunction induces ER stress via activation of unfolded protein response. The disturbance of cellular energy generating
pathways [mitochondrial (KC, Krebs cycle) and glycolytic (phosphofructokinase, PFK)] inhibits mTOR activity and, thereby, enhances autophagy. The interplay of ER
stress and autophagy activates IL8 release.
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of the University of Heidelberg. We received written informed
consent for all cell lines included in this study.
Cell culture
Cells were prepared from urine of healthy donors (n = 9) and pa-
tients with mut0 (n = 5) and cblB (n = 1) defects as well as patients
affected with PAuria (n = 3) and puriﬁed tubular epithelial cells
(hTEC). Primary epithelial cells of human proximal tubule were
cultured in a selective medium containing Dulbecco’s Modiﬁed
Eagle Medium and Ham’s F12 medium. It was supplemented
with fetal calf serum, insuline, hydrocortisone, selenite, transfer-
rin, hEGF, NAD and tri-iodo-thyronine. Conﬂuent cells were sub-
cultivated until 3rd passage and, subsequently, immortalized
using pRSVneo vector containing SV40DNA (pRNS1). Afterwards,
immortalized tubular epithelial cells (hTEC) were characterized
regarding morphology and protein expression.
Antibodies
The following antibodies were used for immunoblotting: rabbit
polyclonal anit p-AMPK (sc-4778, Santa Cruz); mouse polyclonal
anti-methylmalonylcoenzyme A mutase (#ab67869; Abcam, Ca-
mebridge, UK); rabbit polyclonal anti-aquaporin 1 (#AB2219;
Millipore, Billerica, USA); rabbit polyclonal anti-aquaporin 2
(#A7310; Sigma, St. Louis, USA); sheep polyclonal anti-uromodu-
lin (#K90071C; Meridian Life Science, Kampenhout, Belgium);
mouse monoclonal anti-beta actin (#A5441; Sigma); rabbit poly-
clonal anti-sheep HRP (P0163; Dako, Glostrup, Denmark); goat
polyclonal anti-rabbit HRP (P0488; Dako); goat polyclonal anti-
mouse HRP (P0447; Dako); rabbit monoclonal anti p-IRE1
(#ab124945; Abcam); rabbit polyclonal anti LC3 (#L7543; Sigma,
St Louis, USA); rabbit polyclonal anti p62 (#sc25575; Santa Cruz).
Immunoblotting
Immunoblotting was performed as previously described (33).
Cells were cultivated until 80% conﬂuence. Monolayers were col-
lected in lysis buffer composed of 1 m EDTA (Merck, Darmstadt,
Germany), 20 m imidazole (AppliChem GmbH, Darmstadt, Ger-
many), 250 m sucrose (VWR, Leuven, Belgium) containing pro-
tease inhibitors (Roche Diagnostics, Mannheim, Germany).
Protein concentration was determined using Pierce BCA Protein
Assay Kit (ThermoScientiﬁc, Rockford, USA). Samples [20 μg pro-
tein/lane] were diluted in Laemmli sample buffer (Bio-Rad, Her-
cules, CA, USA) and heated to 95°C for 6 min followed by
sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis
(PAGE) and blotting on nitrocellulose membranes (Bio-Rad, Mun-
ich, Germany). Membraneswere blocked 2 h at room temperature
in non-fat drymilk (Bio-Rad, Hercules, CA, USA) followed by over-
night incubation at 4°C with primary antibodies. After washing
blots were incubated with peroxidase-conjugated secondary
antibodies, washed again and visualized by Immun-Star en-
hanced chemiluminescence (Bio-Rad, Hempstead, UK). For
quantitative analyses of western blots a FusionExpress system
from peqlab was applied.
Mcm activity
Cells derived from human urine were classiﬁed as having mut0
and cblB mutations by the assay of MCM activity. MCM activity
was assayed in crude cell homogenates with (total MCM) and
without (apo-MCM) the cofactor AdoCbl (50 mol/l) as described
before (34).
Oxygen electrode
By using computer-supported high-resolution Oroboros 1 oxy-
graph system (Paar, Graz, Austria) mitochondrial respiratory
ratewas determined according to a previously described protocol
(35). hTEC of controls and patients were placed in each electrode
chamber. ‘Mitochondrial respiratory rate (respiration-dependent
ATP production)’ was calculated by subtracting ‘Background oxy-
gen consumption rate (proton leak)’ (recorded with a reference
electrode in a presence of 10 μ NaCN) from ‘Total oxygen con-
sumption rate’.
Enzymes of cellular energy production
Activity of single enzyme complexes of electron transport chain,
glycolysis and citrate cyclewere recorded according to previously
published protocols (12,36). A computer-tuneable spectropho-
tometer (Spectramax Plus Microplate Reader, Molecular Devices;
SunnyVale, CA, USA) operating in the dualwavelengthmodewas
used. Measurement of the samples was performed in tempera-
ture-controlled 96-well plates in a ﬁnal volume of 300 ml.
Radiometric analysis
Studies on the metabolism of 14C-pyruvate and 14C-2-oxogluta-
rate were performed according to previously published protocols
(14).
Determination of ROS
Reactive oxygen species were measured by H2DCFDA staining.
Cells were stained with H2DCFDA (10 μ) for 30 min. Then ROS
generation was determined by FACS analysis (Canto II, Becton
Dickinson).
Acridine orange staining
Cells were cultured in 6 cm petri dishes for 48 h in and, after-
wards, incubated with acridine orange (1 μg/ml) colorless
DMEM at 37°C for 20 min. Detection of green and red ﬂuorescent
cells was performed using a FACS system (Canto II, Becton
Dickinson).
mTOR regulation
Regulation of mTOR signaling was analyzed using mTOR Regula-
tion Antibody Sampler Kit (#9864; Cell Signaling) according to the
manufacturer’s protocol.
Determination of cytokines
To screen for changes in expression and secretion cytokines we
used a Mix-N-Match ELISArray (SA Bioscience including IL8,
MCP1, MIP-1a, MIP-1b, RANTES, TGF-ß) according to the manu-
facturer’s protocol. IL-8 concentration was measured by en-
zyme-linked immunosorbent assay (ELISA) (Gen-probe, Eli-pair
IL-8) again according to the manufacturer’s protocol. For these
experiments, hTEC were grown on 12-well TransWell ﬁlter plates
for 48 h in standardmedium. Thereafter, cells werewashed twice
with PBS and cultured inmediumwithout FCS for 24 h. Thenme-
dium from the basolateral and apical site of well was collected,
cells were harvested andmedium and cell lysates were analyzed.
Electron micrographs
Cells were ﬁxed with 1:1:1 (v/v) mixture of 0.05% ruthenium
red (AppliChem; Darmstadt, Germany), 2.5% glutaraldehyde
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(SERVA; Heidelberg, Germany) and cacodylate buffer, 2 h at
RT. After washing with 0.2 M cacodylate buffer, cells were post-
ﬁxed with with 1:1:1 (v/v) of 0.05% ruthenium red, 0.2 M
cacodylate buffer and 2% osmium tetroxide (Chempur; Karls-
ruhe, Germany) for 2 h at RT. Next, cells were washed with caco-
dylate buffer and dehydrated with serial ethanol concentrations
(50, 80, 96 and 100%). Samples were embedded in Araldite
(SERVA), contrasted with uranylacetate and lead citrate and sec-
tionedwith Ultracut 70 nm (Leica; Solms, Germany). Imageswere
captured using EM 910 (Zeiss; Oberkochen, Germany).
Statistical analysis
Experiments were performed at least in triplicates. Data are ana-
lyzed using Mann–Whitney U tests for pairwise comparison and
Kruskal–Wallis H testwith subsequentMann–WhitneyU tests for
multiple comparison (SPSS for Windows 16.0 Software).
Supplementary Material
Supplementary Material is available at HMG online.
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